Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 29, 2016
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - August 29, 2016

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/29/16 - "Novel Insulin Derivatives" in Patent Application Approval Process (USPTO 20160229902)
By a News Reporter-Staff News Editor at Diabetes Week A patent application by the inventors Hoeg-Jensen, Thomas; Jakobsen, Palle; Sensfuss, Ulrich; Fledelius, Christian; Ribel-Madsen, Ulla, filed on April 18, 2016, was made available online on August 18, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents
8/29/16 - "Reduction of Flake-Like Aggregation in Nanoparticulate Active Agent Compositions" in Patent Application Approval Process (USPTO 20160228555)
"Nanoparticulate active agent compositions, first described in U.S. Pat. "Methods of making nanoparticulate active agent compositions are described in, for example, U.S. Pat. Nos. 5,518,187 and 5,862,999, both for' Method of Grinding Pharmaceutical Substances;' U.S. Pat.
8/29/16 - 5 Top NASDAQ Stocks: Amedica Up Over 50 Percent
Despite that, these five companies recorded gains above 30 percent: Amedica Corp., Nymox Pharmaceutical, Clovis Oncology, Cellectar Biosciences, and Adamis Pharmaceuticals. According to the World Health Organization, "the pharmaceutical industry is expected to go from $300 billion to $400 billion within the next 3 years." Click here to download a F
8/29/16 - Acadia Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Aug. 12, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on August 12, 2016. The SEC file number is 0001638599-16-001262.. A U.S. Securities and Exchange Commission fi
8/29/16 - Acadia Pharmaceuticals Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (Aug. 12, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on August 12, 2016. The SEC file number is 0001193125-16-680811.. A U.S. Securities and Exchange Commission fi
8/29/16 - Acadia Pharmaceuticals Inc. Files SEC Form SC 13D/A, General Statement of Acquisition of Beneficial Ownership (Aug. 12, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acadia Pharmaceuticals Inc. was posted on August 12, 2016. The SEC file number is 0001144204-16-118749.. A U.S. Securities and Exchange Commission fi
8/29/16 - Acceleron Pharma Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Aug. 11, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on August 11, 2016. The SEC file number is 0001179110-16-028589.. A U.S. Securities and Exchange Commission filing i
8/29/16 - Acelrx Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acelrx Pharmaceuticals Inc. was posted on August 15, 2016. The SEC file number is 0001437749-16-037360.. A U.S. Securities and Exchange Commission fi
8/29/16 - Acura Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report (Aug. 16, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on August 16, 2016. The SEC file number is 0001144204-16-119781.. A U.S. Securities and Exchange Commission fi
8/29/16 - Aeolus Pharmaceuticals, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeolus Pharmaceuticals, Inc. was posted on August 15, 2016. The SEC file number is 0001102624-16-003292.. A U.S. Securities and Exchange Commission f
8/29/16 - Agios Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Aug. 11, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agios Pharmaceuticals Inc. was posted on August 11, 2016. The SEC file number is 0001209191-16-136570.. A U.S. Securities and Exchange Commission fil
8/29/16 - Agios Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Aug. 16, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agios Pharmaceuticals Inc. was posted on August 16, 2016. The SEC file number is 0001193125-16-683118.. A U.S. Securities and Exchange Commission fil
8/29/16 - Alere Receives FDA Clearance for Alere i RSV Rapid Molecular Test
By a News Reporter-Staff News Editor at Pharma Business Week Alere Inc., a global leader in rapid diagnostics, announced that its Alere? i RSV test has received 510 marketing clearance from the U.S. Food and Drug Administration for the detection of RSV infection in children and adults. Following Alere? i Influenza A& B and Alere? i Strep A,
8/29/16 - Amphastar Pharmaceuticals, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Amphastar Pharmaceuticals, Inc. was posted on August 15, 2016. The SEC file number is 0000899243-16-027176.. A U.S. Securities and Exchange Commissio
8/29/16 - An Application for the Trademark "A TRUSTED RESOURCE FOR MOMS" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "A TRUSTED RESOURCE FOR MOMS" by Nadine P. Flynn, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Nadine P. Flynn,
8/29/16 - An Application for the Trademark "ENFAMIL NURSETTE" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "ENFAMIL NURSETTE" by Tanya Fickenscher, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Tanya Fickenscher, Bristol
8/29/16 - An Application for the Trademark "JILITY" Has Been Filed by Eli Lilly
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "JILITY" by Robert E. Lee, Jr., representing Eli Lilly. The owner/registrar information for this application is: Robert E. Lee, Jr., Eli Lilly, Lilly Corporate
8/29/16 - An Application for the Trademark "SMART SYMPHONIES" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "SMART SYMPHONIES" by Christopher N. Bolinger, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Christopher N. Bolin
8/29/16 - An Application for the Trademark "TRI-VI-SOL" Has Been Filed by Bristol-Myers Squibb
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "TRI-VI-SOL" by Anthony J. Franze, representing Bristol-Myers Squibb. The owner/registrar information for this application is: Anthony J. Franze, Bristol-Myers
8/29/16 - Antares Pharma, Inc. Files SEC Form 8-K, Current Report (Aug. 11, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Antares Pharma, Inc. was posted on August 11, 2016. The SEC file number is 0001564590-16-023987.. A U.S. Securities and Exchange Commission filing is
8/29/16 - Arena Pharmaceuticals Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arena Pharmaceuticals Inc. was posted on August 15, 2016. The SEC file number is 0001657494-16-000006.. A U.S. Securities and Exchange Commission fil
8/29/16 - Arena Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arena Pharmaceuticals Inc. was posted on August 15, 2016. The SEC file number is 0001657494-16-000007.. A U.S. Securities and Exchange Commission fil
8/29/16 - Arena Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Arena Pharmaceuticals Inc. was posted on August 15, 2016. The SEC file number is 0001193125-16-681869.. A U.S. Securities and Exchange Commission fil
8/29/16 - Ariad Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Aug. 15, 2016)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Ariad Pharmaceuticals Inc. was posted on August 15, 2016. The SEC file number is 0000884731-16-000097.. A U.S. Securities and Exchange Commission fil
8/29/16 - ARMO BioSciences Announces Publication of AM0010 Clinical Data in Advanced Solid Tumor Patients in Journal of Clinical Oncology JCO
By a News Reporter-Staff News Editor at Clinical Trials Week ARMO BioSciences, Inc., a clinical-stage biotechnology company, announced that the Journal of Clinical Oncology has published clinical safety and efficacy data on the Company's lead investigational immuno-oncology drug AM0010 in patients with advanced solid tumors. "The results of this
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415